These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8195039)

  • 21. Effects of the long-term depletion of reduced glutathione in mice administered L-buthionine-S,R-sulfoximine.
    Sun JD; Ragsdale SS; Benson JM; Henderson RF
    Fundam Appl Toxicol; 1985 Oct; 5(5):913-9. PubMed ID: 2866140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutathione depletion and cytotoxicity of buthionine sulphoximine and SR2508 in rodent and human cells.
    Ling CC; Wong RS; Basas RD
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):325-30. PubMed ID: 2137437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of BSO and DEM on thiol-level and radiosensitivity in HeLa cells.
    Vos O; van der Schans GP; Roos-Verhey WS
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1249-53. PubMed ID: 6469746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of misonidazole radiosensitization by buthionine sulphoximine.
    Rojas A; Smith KA; Soranson JA; Minchinton AI; Middleton RW; Denekamp J
    Radiother Oncol; 1984 Dec; 2(4):325-32. PubMed ID: 6522642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine.
    Lee FY; Allalunis-Turner MJ; Siemann DW
    Br J Cancer; 1987 Jul; 56(1):33-8. PubMed ID: 3620316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of D,L-buthionine-S,R-sulfoximine on cellular thiol levels and the oxygen effect in Chinese hamster V79 cells.
    Astor MB; Hall EJ; Biaglow JE; Hartog B
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1239-42. PubMed ID: 6469744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells.
    Dorr RT; Liddil JD; Soble MJ
    Invest New Drugs; 1986; 4(4):305-13. PubMed ID: 3583642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exogenous glutathione attenuates the antiproliferative effect of buthionine sulfoximine.
    Kang YJ
    Toxicology; 1994 Mar; 88(1-3):177-89. PubMed ID: 8160199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation.
    Drew R; Miners JO
    Biochem Pharmacol; 1984 Oct; 33(19):2989-94. PubMed ID: 6148944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buthionine sulfoximine-induced cytostasis does not correlate with glutathione depletion.
    Kang YJ; Enger MD
    Am J Physiol; 1992 Jan; 262(1 Pt 1):C122-7. PubMed ID: 1733228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buthionine sulfoximine induced growth inhibition in human lung carcinoma cells does not correlate with glutathione depletion.
    Kang YJ; Emery D; Enger MD
    Cell Biol Toxicol; 1991 Jul; 7(3):249-61. PubMed ID: 1933516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the acute toxicity of methyl chloride in male B6C3F1 mice by glutathione depletion.
    Chellman GJ; White RD; Norton RM; Bus JS
    Toxicol Appl Pharmacol; 1986 Oct; 86(1):93-104. PubMed ID: 3764938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of X ray DNA damage by SR-2508 +/- buthionine sulfoximine.
    Kinsella TJ; Dobson PP; Russo A; Mitchell JB; Fornace AJ
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1127-30. PubMed ID: 2943711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of thiols in cellular response to radiation and drugs.
    Biaglow JE; Varnes ME; Clark EP; Epp ER
    Radiat Res; 1983 Sep; 95(3):437-55. PubMed ID: 6684310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective toxicity of buthionine sulfoximine (BSO) to melanoma cells in vitro and in vivo.
    Révész L; Edgren MR; Wainson AA
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):403-6. PubMed ID: 8195041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential sensitivities of murine melanocytes and melanoma cells to buthionine sulfoximine and anticancer drugs.
    Thrall BD; Raha GA; Springer DL; Meadows GG
    Pigment Cell Res; 1991 Dec; 4(5-6):234-9. PubMed ID: 1823927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
    Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK
    Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-buthionine-sulfoximine-mediated radiosensitization in experimental interstitial radiotherapy of intracerebral D-54 MG glioma xenografts in athymic mice.
    Lippitz BE; Halperin EC; Griffith OW; Colvin OM; Honore G; Ostertag CB; Bigner DD; Friedman HS
    Neurosurgery; 1990 Feb; 26(2):255-60. PubMed ID: 2308673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U; Schorn H
    Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.